Posts in category

NEWS


A former Coles general manager has been appointed as executive director of Chemmart. Duncan Phillips will lead Chemmart bringing with him his extensive Australian and overseas retail experience. Phillips joined …

Thousands of superheroes will next week take over workplaces and schools around the country with more than 200 organisations registered for National Superhero Week (August 31 to September 4) to …

Children who have suffered accidental injury are being helped by using a website that gives them information and coping skills, helping prevent PTSD, researchers have found. The researchers, led by …

Novo Nordisk is rolling out a host of primary care tools to support pharmacy’s diabetes patients; identify people who may not have been diagnosed; and reduce the rates of people …

To help pharmacists ‘visualise’ the acid pocket concept and Gaviscon mode of action, RB teamed up with an expert bartender and community pharmacist Stuart Nankivell to create a short educational …

RB’s competition with Adriano Zumbo closes on Monday 31 August, and this is your last chance to enter! All you have to do is complete your Nuromol® product training module …

The Generic and Biosimilar Medicines Association has welcomes the recommendation by the PBAC to list biosimilar infliximab (Inflectra) on the PBS and to recommend the marking as equivalent, also known …

In a few weeks, hundreds of pharmacy assistants will make their way to the Gold Coast for the annual Pharmacy Assistant National Conference (PA2015); allowing them to attend can be …

Medicines Australia has expressed concern about the PBAC’s recommendation that pharmacists be allowed to substitute the biosimilars in place of biologic medicines prescribed by a patient’s doctor. “The so-called ‘a-flagging’ …

The Federal Government needs to list new hepatitis C medicines on the PBS without further delay, according to the peak body representing the interests of a quarter of a million …

Three Australian research teams have been awarded grants as part of a global effort to combat the growing incidence of type 2 diabetes, which affects more than 300 million people …

The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …